Biologics Production Manufacturing Insurance: Safeguarding Your Pharmaceutical Innovation
Introduction: The Complex World of Biologics Manufacturing
Biologics manufacturing represents the cutting edge o…






Pharmaceutical manufacturing combines high-value assets, strict regulatory obligations, and potentially high-severity claims. You may operate cleanrooms, sterile suites, high-potency containment, complex utilities (HVAC, compressed air, steam, purified water/WFI), and sophisticated machinery. At the same time, you may be under contract to supply customers with strict quality agreements, audit rights, and penalty clauses.
That combination creates a simple truth: pharmaceutical manufacturers rarely need a single insurance policy — they need an insurance programme. The correct programme depends on what you do (API manufacturing, drug formulation, fill-finish, packaging, warehousing, clinical supply, nutraceuticals), how you do it (sterile/non-sterile, shared facilities, outsourcing), where you sell (UK, EU, US, worldwide), and the structure of your contracts.
This page explains the most common covers pharmaceutical manufacturers and CDMOs typically need, how the covers fit together, and the underwriting information insurers usually require. If you want tailored advice, call Insure24 on 0330 127 2333 or start a quote online.
Most pharmaceutical manufacturing businesses will start with a core set of covers that protect people, premises, and third parties. These are the foundations of a manufacturing insurance programme. From there, you add specialist sections that address GMP-specific loss pathways such as contamination, recall/withdrawal, cleanroom shutdowns and high dependency equipment.
If you employ staff in the UK, Employers’ Liability (EL) insurance is generally required by law (subject to limited exceptions). It protects your business if employees allege injury or illness arising out of their work. In pharmaceutical manufacturing, EL exposures can include manual handling injuries, chemical exposure, sensitiser exposure, slips and trips, repetitive strain, and accidents involving machinery, forklifts, or pressurised systems.
EL is not a “box-tick” in pharma: underwriters may ask about safety culture, COSHH controls, training, PPE, and incident history.
Public liability (PL) covers third-party injury or property damage claims arising from your premises or operations. Pharmaceutical sites regularly host third parties: delivery drivers, auditors, regulators, customers, contractors, calibration teams, and facilities specialists. If a visitor is injured on-site, or their property is damaged, a PL claim can follow — and legal defence costs can be significant even when liability is disputed.
If you have frequent contractors or construction works, ensure your policy wording aligns with those activities and any permit-to-work regimes.
Product liability covers claims that your product caused injury, illness or property damage after it was supplied. For pharmaceutical manufacturers, the severity potential is high, especially for sterile products, injectable products, and products supplied internationally. Even where patient harm does not occur, legal defence costs and investigation complexity can be substantial.
Product liability is essential — but it is not the same as recall insurance. Many businesses incorrectly assume recall costs are included within product liability; often they are not.
Property insurance protects your physical assets: buildings (if you own them), tenant improvements, machinery, contents, and stock (raw materials, work-in-progress, finished goods). Pharmaceutical facilities often contain high-value equipment, controlled storage areas, temperature-sensitive stock, and complex infrastructure.
Accurate sums insured and correct descriptions matter. Underinsurance can reduce claim payments, and misdescribing your activities can lead to coverage disputes.
The specialist sections below are where pharmaceutical insurance differs from general manufacturing. These covers respond to the “real world” pathways of loss: contamination investigations, batch failure, withdrawals, cleanroom shutdowns, and dependency on critical equipment and utilities.
Business interruption (BI) covers loss of gross profit and (often) increased cost of working when you cannot operate normally following an insured event. In pharmaceutical manufacturing, downtime is frequently driven by more than repairs: cleaning, revalidation, requalification, environmental trend confirmation and batch release testing can extend recovery.
BI is one of the most common areas of underinsurance in regulated manufacturing because restoration of “compliant trading capacity” can take longer than expected.
Recall/withdrawal cover is designed to pay the operational costs of removing product from the supply chain: retrieval, returns handling, disposal, communications and sometimes specialist crisis support. This cover is crucial where contracts require rapid response — or where your distribution model increases the complexity of retrieval (multiple wholesalers, direct-to-hospital, export markets).
This cover is typically separate from product liability. If you have multi-client exposure (CDMO), ensure the policy aligns with responsibilities under quality agreements.
Machinery breakdown cover insures sudden and accidental breakdown of insured equipment (subject to schedule and definitions). This can be critical for pharmaceutical operations that depend on: tablet presses, encapsulators, filling lines, autoclaves, lyophilisers, chillers, compressors, AHUs and control systems.
The value is not only the repair cost — it’s the downtime prevention and the ability to fund rapid mitigation when a critical line fails.
If you store temperature-sensitive materials or finished goods (including cold chain products), deterioration of stock extensions can be vital. Pharmaceutical stock can be high-value, and a single refrigeration or monitoring failure can compromise large volumes.
Where cold storage is business-critical, insurers will focus on resilience: redundancy, alarms, emergency response, and maintenance.
Many pharmaceutical manufacturers do more than “make”. CDMOs and specialist manufacturers often provide formulation work, tech transfer support, stability planning, specification advice, validation services, or regulatory documentation support for clients. Where you provide professional services, professional indemnity (PI) can protect against claims alleging errors or negligence in advice.
PI is not always required for every manufacturer, but if your contracts include advisory responsibility, it’s worth reviewing.
Pharmaceutical operations are data-heavy: batch records, quality systems, equipment control systems, supplier qualification data, and customer audits. Cyber incidents can interrupt production, compromise data integrity, and trigger notification obligations depending on the nature of the data involved.
Cyber is not a replacement for operational resilience, but it can provide a structured response capability when incidents occur.
“Our biggest risk wasn’t just physical damage — it was the time to investigate, clean, revalidate and restart. Structuring BI and recall correctly made all the difference.”
Operations Manager, UK Pharmaceutical ManufacturerThe right insurance programme depends on your operation and where losses are likely to occur. A small non-sterile packaging site will have different needs from an aseptic fill-finish facility or an API manufacturer handling hazardous solvents and high temperature processes. Below are practical ways to tailor cover.
Ask: what event is most likely to stop production or damage product integrity? Common pathways include:
Once pathways are clear, you can structure BI, breakdown and recall to respond to those triggers.
Many programmes are built to satisfy contracts. Customers may specify minimum limits for product liability, PI, and public liability, and may impose notification obligations after incidents. Landlords may specify property and liability clauses. Logistics partners may require specific limits for goods in transit or third-party liability.
Insurance should align with contract reality — otherwise you can be “insured” but still contractually exposed.
Insure24 arranges specialist insurance for pharmaceutical manufacturers, life-sciences producers, and contract manufacturing organisations (CDMOs). We help you build a programme that is commercially sensible, contract-aligned, and realistic about how GMP downtime and quality incidents unfold.
If you want a quick sense-check on your current insurance, call us on 0330 127 2333. We’ll help identify gaps, underinsurance risks, and the covers that make the biggest difference for your operation.
What insurance is legally required for a pharmaceutical manufacturer in the UK?
Is product recall covered under product liability insurance?
What’s the most common underinsurance risk in pharmaceutical manufacturing?
Do CDMOs need professional indemnity insurance?
How much product liability cover should a pharmaceutical manufacturer buy?
How do I get a quote for pharmaceutical manufacturing insurance?
Biologics manufacturing represents the cutting edge o…
The oral medication manufactur…
In the highly regulated and precision-driven world of tablet and capsule production, comprehensive insurance is not ju…
Published: September 2025 | Insure24 Pharmaceutical Insurance Specialists
The pharmaceutical manufacturing…
The monoclonal an…
Published: September 2025 | Insure24 Commercial Insurance Guides